Emega Soft Capsule 300mg (Eicosapentaenoic Acid Ethyl)

Adult dose

1. Improvement of ulcers, pain, and coldness caused by obliterative arteriosclerosis Adults: Administer ethyl icosapentate 600mg (2 capsules) orally 3 times daily immediately after meals. 2. Hyperlipidemia Administer ethyl icosapentate 900mg (3 capsules) orally twice daily or 600mg (2 capsules) orally 3 times daily immediately after meals. If an abnormal triglyceride level occurs, the dose may be increased, if needed, to 900mg (3 capsules) 3 times daily.

This drug should not be used in patients with allergies to any of its components. Administration in patients with bleeding may lead to difficulties in blood coagulation, so it should be avoided. Caution is required for patients who are menstruating, those with a tendency to bleed, and those scheduled for surgery as there may be increased risk of bleeding. Patients at high risk of bleeding due to severe trauma or those with decreased liver function should also be careful. Patients with fish allergies may exhibit hypersensitivity reactions; caution is advised. Patients taking anticoagulants or antiplatelet agents should consult a professional due to increased risk of bleeding. Liver function abnormalities or jaundice symptoms may occur; liver condition should be monitored regularly, and if abnormalities appear, discontinue use immediately. There may be an increased risk of cardiac arrhythmias such as atrial fibrillation or atrial flutter, so it's important to check heart health. If symptoms such as rash, itching, bleeding, dyspepsia, headache, or dizziness occur during use, consult medical professionals immediately. This drug should be used alongside dietary and exercise therapies for hyperlipidemia treatment and regular blood tests should be conducted to check effectiveness. Patients whose blood pressure is uncontrolled or who are taking other antiplatelet agents should exercise caution due to the risk of cerebral hemorrhage. Use during pregnancy or in women with the possibility of pregnancy should be carefully considered, and breastfeeding women should preferably avoid use. Safety in children has not been established, so it is advisable not to use it. This drug should be taken immediately after meals for optimal absorption and must be swallowed whole without chewing. Store out of reach of children, and after opening, keep it away from high temperature, humidity, and light, and do not transfer it to another container for safety.

• Liver dysfunction
• jaundice
• atrial fibrillation
• atrial flutter
• hypersensitivity
• rash
• itching
• tendency to bleed
• subcutaneous bleeding
• hematuria

This drug should be stored in a sealed container to protect it from exposure to air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

Colorless or pale yellow transparent liquid contained in a colorless transparent oval soft capsule

Package unit

60 capsules/box [(10 capsules/PTP) X 6], 120 capsules/box [(10 capsules/PTP) X 12]